Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-03-12 | 2018-12-18 | 716 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 719 |
APO-LOSARTAN | 50MG | TABLET | Resolved | 2017-03-12 | 2017-03-16 | 722 |
APO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-03-12 | 2017-03-31 | 725 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-03-12 | 2017-10-10 | 728 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-03-12 | 2017-03-16 | 731 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-03-12 | 2017-03-16 | 734 |
APO-LATANOPROST-TIMOP | 5MG 50MCG | SOLUTION | Resolved | 2017-03-13 | 2018-09-11 | 739 |
APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2017-03-13 | 2017-03-29 | 742 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2017-03-13 | 2017-04-20 | 745 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-03-13 | 2017-03-31 | 748 |
APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2017-03-13 | 2017-03-31 | 2019 |
APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2017-03-16 | 2017-10-03 | 3083 |
APO-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2017-03-17 | 2017-07-17 | 3160 |
APO-CEFUROXIME | 500MG | TABLET | Resolved | 2017-03-17 | 2017-06-12 | 3163 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-03-17 | 2017-07-20 | 3169 |
APO-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-17 | 2017-06-23 | 3175 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-03-17 | 2017-07-26 | 3180 |
APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-03-17 | 2017-06-01 | 3183 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-03-17 | 2017-05-01 | 3186 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |